VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease

Diether Lambrechts; Peter Carmeliet

doi:10.1016/j.bbadis.2006.04.005

Related publications

Article2011

The Neurovascular Link in Health and Disease: Molecular Mechanisms and Therapeutic Implications

Annelies Quaegebeur, Christian Lange, Peter Carmeliet

Article2004

Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration

Ludo Van Den Bosch, Erik Storkebaum, V. Vleminckx, Lieve Moons, Ludo Vanopdenbosch, Wendy Scheveneels, Peter Carmeliet, Wim Robberecht

Article2019

Survival prediction models in motor neuron disease

Federica Agosta, Edoardo Gioele Spinelli, Nilo Riva, Andrea Fontana, Silvia Basaia, Elisa Canu, Veronica Castelnovo, Yuri Falzone, Paola Carrera, Gıancarlo Comı, Massimo Filippi

Article2008

Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration

Koen Poesen, Diether Lambrechts, Philip Van Damme, Joke Dhondt, Florian L. P. Bender, Nicolas Frank, Elke Bogaert, Bart Claes, Line Heylen, An Verheyen, Katrien Raes, Marc Tjwa, Ulf Eriksson, Masabumi Shibuya, Rony Nuydens, Ludo Van Den Bosch, Theo Meert, Rudi D’Hooge, Michael Sendtner, Wim Robberecht, Peter Carmeliet

Article2003

VEGF, a modifier of motor neuron degeneration in SOD1 G93A mice, protects against motor neuron loss after spinal cord ischemia: evidence for a vascular hypothesis

Erik Storkebaum, Diether Lambrechts, Miwako Sakai Masafumi, G. Vandenhoutte, A. Vanderlinden, Désiré Collen, Veerle Baekelandt, Lieve Moons, Peter Carmeliet